Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena

KARALOGLU, D
Yasasever, V
DALAY, N
CAMLICA, Hakan
DINCER, M

Open link

Publication date

January 1997

DOI

10.1016/s0009-9120(96)00133-6

Publisher

Elsevier BV

Journal

Clinical Biochemistry

Abstract

Objectives: CA 15-3 and CEA are considered useful tumor markers in monitoring breast cancer patients. This study was undertaken to specifically evaluate the transient elevations in these markers that are observed during systemic treatment for metastatic disease. This phenomenon has been termed ''spiking.'

Extracted data

We use cookies to provide a better user experience.

Data Protection

Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena

Abstract

Extracted data

Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena

Abstract

Extracted data

Related items

Related items